495 related articles for article (PubMed ID: 18500533)
21. Dorsal pancreatic duct dominance in pancreaticobiliary maljunction.
Kamisawa T; Egawa N; Nakajima H; Matsukawa M
Pancreas; 2005 Apr; 30(3):e60-3. PubMed ID: 15782090
[TBL] [Abstract][Full Text] [Related]
22. A case of pancreaticobiliary maljunction with a connecting duct without a long common channel.
Kikuyama M; Kamisawa T; Kuruma S; Chiba K; Koizumi S; Tabata T; Honda G
Clin J Gastroenterol; 2017 Apr; 10(2):196-199. PubMed ID: 28229343
[TBL] [Abstract][Full Text] [Related]
23. Pancreas divisum in pancreaticobiliary maljunction.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2008; 55(81):249-53. PubMed ID: 18507118
[TBL] [Abstract][Full Text] [Related]
24. Precancerous conditions of biliary tract cancer in patients with pancreaticobiliary maljunction: reappraisal of nationwide survey in Japan.
Hasumi A; Matsui H; Sugioka A; Uyama I; Komori Y; Fujita J; Aoki H
J Hepatobiliary Pancreat Surg; 2000; 7(6):551-5. PubMed ID: 11180886
[TBL] [Abstract][Full Text] [Related]
25. Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction.
Kobayashi S; Asano T; Yamasaki M; Kenmochi T; Nakagohri T; Ochiai T
Surgery; 1999 Nov; 126(5):939-44. PubMed ID: 10568195
[TBL] [Abstract][Full Text] [Related]
26. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
27. Intracholecystic papillary neoplasm arising in a patient with pancreaticobiliary maljunction: a case report.
Iwasaki T; Otsuka Y; Miyata Y; Einama T; Tsujimoto H; Ueno H; Ogata S; Kishi Y
World J Surg Oncol; 2020 Nov; 18(1):292. PubMed ID: 33168026
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic diagnosis of pancreaticobiliary maljunction.
Kamisawa T; Takuma K; Itokawa F; Itoi T
World J Gastrointest Endosc; 2011 Jan; 3(1):1-5. PubMed ID: 21258599
[TBL] [Abstract][Full Text] [Related]
29. p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Funabiki T; Jinno O; Sakurai Y; Hasegawa S; Imazu H; Ochiai M
J Hepatobiliary Pancreat Surg; 1999; 6(3):286-93. PubMed ID: 10526065
[TBL] [Abstract][Full Text] [Related]
30. Preferable operative age of choledochal dilation types to prevent patients with pancreaticobiliary maljunction from developing biliary tract carcinogenesis.
Kobayashi S; Ohnuma N; Yoshida H; Ohtsuka Y; Terui K; Asano T; Ryu M; Ochiai T
Surgery; 2006 Jan; 139(1):33-8. PubMed ID: 16364715
[TBL] [Abstract][Full Text] [Related]
31. Association of anomalous pancreaticobiliary ductal junction with gallbladder carcinoma in Chinese patients: an ERCP study.
Hu B; Gong B; Zhou DY
Gastrointest Endosc; 2003 Apr; 57(4):541-5. PubMed ID: 12665766
[TBL] [Abstract][Full Text] [Related]
32. [A case of synchronous cancer of the gall bladder, common bile duct, and the papilla of vater].
Ueno G; Ishikawa S; Ichikawa Y; Hagi T; Taniura N; Chong H; Kanazawa A; Takayama S; Nishihara M; Maruyama K; Shimada M; Lee K; Oka H; Maeda T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1521-3. PubMed ID: 25731239
[TBL] [Abstract][Full Text] [Related]
33. Carcinogenesis in the biliary system associated with APDJ.
Chao TC; Wang CS; Jan YY; Chen HM; Chen MF
J Hepatobiliary Pancreat Surg; 1999; 6(3):218-22. PubMed ID: 10526055
[TBL] [Abstract][Full Text] [Related]
34. IL-33 overexpression in gallbladder cancers associated with pancreatobiliary maljunction.
Tomioka Y; Sung YN; Sawada R; Hong SM; Akita M; Itoh T; Ajiki T; Fukumoto T; Zen Y
Histopathology; 2019 Sep; 75(3):365-375. PubMed ID: 30882917
[TBL] [Abstract][Full Text] [Related]
35. Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction.
Tsuchida A; Itoi T
World J Gastrointest Oncol; 2010 Mar; 2(3):130-5. PubMed ID: 21160820
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation.
Ohuchida J; Chijiiwa K; Hiyoshi M; Kobayashi K; Konomi H; Tanaka M
Arch Surg; 2006 Nov; 141(11):1066-70. PubMed ID: 17116798
[TBL] [Abstract][Full Text] [Related]
37. Pancreaticobiliary maljunction and choledochal cysts: from embryogenesis to therapeutics aspects.
Le Roy B; Gagnière J; Filaire L; Fontarensky M; Hordonneau C; Buc E
Surg Radiol Anat; 2016 Nov; 38(9):1053-1060. PubMed ID: 27003810
[TBL] [Abstract][Full Text] [Related]
38. A case of congenital biliary dilatation without pancreaticobiliary maljunction, so-called Type Ib according to Todani's classification.
Kiyoshita Y; Ishii Y; Serikawa M; Nakamura S; Ikemoto J; Tamura Y; Miyamoto S; Nakamura K; Furukawa M; Oka S
Clin J Gastroenterol; 2024 Feb; 17(1):177-182. PubMed ID: 37851209
[TBL] [Abstract][Full Text] [Related]
39. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union.
Jung YS; Lee KJ; Kim H; Kim WH; Kim IG; Yoo BM; Kim JH; Kim MW
Hepatogastroenterology; 2004; 51(58):946-9. PubMed ID: 15239220
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of 8-hydroxy-2'-deoxyguanosine in gallbladder epithelium of patients with pancreaticobiliary maljunction.
Otani K; Shimizu S; Chijiiwa K; Yamaguchi K; Noshiro H; Tanaka M
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1363-9. PubMed ID: 11692064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
